A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites
Clinical trial NCT04184895 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04184895
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-09
- Primary completion
- 2022-12-22
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.